Monster Breakouts Chart #1 – Biogen Idec (BIIB)
Biogen Idec (BIIB) formed a 7 month cup with handle base that from March 2010 through October 2010. Since its breakout, the stock has returned investors over 80%.Original post: Monster Breakouts Chart #1 – Biogen Idec (BIIB)
102 Stocks Which Gained at Least 50% Year to Date
Has Biogen Idec Become Too Expensive? (BIIB)
Biogen Idec Inc. (NASDAQ: BIIB) is up nearly 4% today on news that ISI Group raised its rating to BUY from HOLD. The driving force is Biogen’s promising MS drug candidate BG-12 with the belief that earnings can grow exponentially in the years ahead. If one company has a lock on the MS market, it [...]
Top Trade Ideas for Thursday, April 21
Sunesis Signs Deal, Improves Pipeline Prospects
Congrats on some plays
So hopefully we all made some good money on the past stock picks. Congrats to all who played and made some money. BIIB – Posted Chart at $70.00…….Hit $72.00 AUMN - Posted the chart for a short with the upper trend line at $23.00…..Hit $19.41 SBUX- Posted chart at $34.00……….Hit $38.21 I will continue [...]
Opexa’s Surge Brings More MS Treatment Hope (OPXA, BIIB, NVS)
Opexa Therapeutics, Inc. (NASDAQ: OPXA) is on fire this morning with investor interest. The company announced that it has successfully completed two End-of Phase 2 meetings with the FDA over its Tovaxin. This is the company’s lead-product candidate and is said to be the first ever personalized T-cell therapy aimed as multiple sclerosis. The company [...]
2011?s Overvalued Big BioHealth Names (AMLN, BIIB, EXEL, ILMN, JAZZ, MDVN, OSIR, SQNM)
It is already 2011 and we have begun the coverage of our annual outlook series. We covered the best of 2010 and an outlook for big-biotech stocks with the most implied upside already. Sometimes it is important to know also which of the big biotech and biohealth names may be overvalued when it comes to [...]
Top BioHealth Analyst Upgrades & Downgrades (AMGN, AZN, BAY, BIIB, CELG, EXAM, GILD, GSK, HGSI, LH, NVS, PFE, UTHR, WCRX)
We have seen many research calls from Wall Street analysts with upgrades, downgrades, and initiations this Tuesday in the world of biotech, pharmaceuticals, and biohealth. Some of the key calls we have seen are as follows: Amgen Inc. (NASDAQ: AMGN) Started as Neutral w/ $58 target at Credit Suisse. AstraZeneca (NYSE: AZN) Cut to Underperform [...]
Safe patterns or contrarian ?
Stocks to watch next week - Earnings Calendar
Fast Money Recap 7/28/10
Stock picks by each of the traders on the latest episode of “Fast Money.” (Fast Money Recaps at Online Traders’ Forum) Buy “Copper” (Steve Cortes) “Crude Oil” (Steve Cortes) “Integrated Oil Stocks” (Terranova) Akamai (AKAM) (analyze) (Jon Najarian) Akamai (AKAM) (analyze) (Terranova) Amgen (AMGN) (analyze) (Mark Schoenebaum) Biogen Idec (BIIB) (analyze) (Mark Schoenebaum) Exxon Mobil (XOM) (analyze) (Terranova) Genzyme (GENZ) (analyze) (Mark Schoenebaum) iShares Nasdaq Biotechnology [...]
US stocks Earnings Calendar for next week
Icahn Boosts Stake in Biogen Idec (BIIB) to 6% Following TYSABRI Sell-Off
What Google thinks of Biogen Idec Inc
Seasonality Analysis of BIIB
Historical data for BIIB
Biogen Idec Inc at ValueWiki
Experimental Head and Shoulders chart patterns identified today
Experimental Inverted Head and Shoulders chart patterns identified today
Stocks with Positive Correlation to BIIB
Stocks with Negative Correlation to BIIB
Previous symbol is BIIAX
Next symbol is BIIBX